1 Study Coverage

• 1.1 mRNA Vaccines & Therapeutics Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global mRNA Vaccines & Therapeutics Market Size Growth Rate by Type
  • 1.4.2 Infectious Disease Vaccines
  • 1.4.3 Cancer Vaccines
• 1.3 Market by Application
  • 1.3.1 Global mRNA Vaccines & Therapeutics Market Size Growth Rate by Application
  • 1.3.2 Standardized Preselected
  • 1.3.3 Prophylactic Vaccines
  • 1.3.4 Individualized Shared Antigens
  • 1.3.5 Synthetic Self-Amplifying Mrna Vaccines for Pandemic Outbreaks
  • 1.3.6 Therapeutic Vaccines
  • 1.3.7 Individualized Neoantigens
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global mRNA Vaccines & Therapeutics Sales Estimates and Forecasts 2016-2027
• 2.2 Global mRNA Vaccines & Therapeutics Revenue Estimates and Forecasts 2016-2027
• 2.3 Global mRNA Vaccines & Therapeutics Revenue by Region: 2016 VS 2021 VS 2027
• 2.4 Global Top mRNA Vaccines & Therapeutics Regions by Sales
  • 2.4.1 Global Top mRNA Vaccines & Therapeutics Regions by Sales (2016-2021)
  • 2.4.2 Global Top mRNA Vaccines & Therapeutics Regions by Sales (2022-2027)
• 2.5 Global Top mRNA Vaccines & Therapeutics Regions by Revenue
  • 2.5.1 Global Top mRNA Vaccines & Therapeutics Regions by Revenue (2016-2021)
  • 2.5.2 Global Top mRNA Vaccines & Therapeutics Regions by Revenue (2022-2027)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global mRNA Vaccines & Therapeutics Sales by Manufacturers
  • 3.1.1 Global Top mRNA Vaccines & Therapeutics Manufacturers by Sales (2016-2021)
  • 3.1.2 Global Top mRNA Vaccines & Therapeutics Manufacturers Market Share by Sales (2016-2021)
  • 3.1.3 Global Top 10 and Top 5 Companies by mRNA Vaccines & Therapeutics Sales in 2020
• 3.2 Global mRNA Vaccines & Therapeutics Revenue by Manufacturers
  • 3.2.1 Global Top mRNA Vaccines & Therapeutics Manufacturers by Revenue (2016-2021)
  • 3.2.2 Global Top mRNA Vaccines & Therapeutics Manufacturers Market Share by Revenue (2016-2021)
  • 3.2.3 Global Top 10 and Top 5 Companies by mRNA Vaccines & Therapeutics Revenue in 2020
• 3.3 Global mRNA Vaccines & Therapeutics Sales Price by Manufacturers
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global mRNA Vaccines & Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global mRNA Vaccines & Therapeutics Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global mRNA Vaccines & Therapeutics Sales by Type
  • 4.1.1 Global mRNA Vaccines & Therapeutics Historical Sales by Type (2016-2021)
  • 4.1.2 Global mRNA Vaccines & Therapeutics Forecasted Sales by Type (2022-2027)
  • 4.1.3 Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2016-2027)
• 4.2 Global mRNA Vaccines & Therapeutics Revenue by Type
  • 4.2.1 Global mRNA Vaccines & Therapeutics Historical Revenue by Type (2016-2021)
  • 4.2.2 Global mRNA Vaccines & Therapeutics Forecasted Revenue by Type (2022-2027)
  • 4.2.3 Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2016-2027)
• 4.3 Global mRNA Vaccines & Therapeutics Price by Type
  • 4.3.1 Global mRNA Vaccines & Therapeutics Price by Type (2016-2021)
  • 4.3.2 Global mRNA Vaccines & Therapeutics Price Forecast by Type (2022-2027)

5 Market Size by Application

• 5.1 Global mRNA Vaccines & Therapeutics Sales by Application
  • 5.1.1 Global mRNA Vaccines & Therapeutics Historical Sales by Application (2016-2021)
  • 5.1.2 Global mRNA Vaccines & Therapeutics Forecasted Sales by Application (2022-2027)
  • 5.1.3 Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2016-2027)
• 5.2 Global mRNA Vaccines & Therapeutics Revenue by Application
  • 5.2.1 Global mRNA Vaccines & Therapeutics Historical Revenue by Application (2016-2021)
  • 5.2.2 Global mRNA Vaccines & Therapeutics Forecasted Revenue by Application (2022-2027)
  • 5.2.3 Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2016-2027)
• 5.3 Global mRNA Vaccines & Therapeutics Price by Application
  • 5.3.1 Global mRNA Vaccines & Therapeutics Price by Application (2016-2021)
  • 5.3.2 Global mRNA Vaccines & Therapeutics Price Forecast by Application (2022-2027)

6 North America

• 6.1 North America mRNA Vaccines & Therapeutics Market Size by Type
  • 6.1.1 North America mRNA Vaccines & Therapeutics Sales by Type (2016-2027)
  • 6.1.2 North America mRNA Vaccines & Therapeutics Revenue by Type (2016-2027)
• 6.2 North America mRNA Vaccines & Therapeutics Market Size by Application
  • 6.2.1 North America mRNA Vaccines & Therapeutics Sales by Application (2016-2027)
  • 6.2.2 North America mRNA Vaccines & Therapeutics Revenue by Application (2016-2027)
• 6.3 North America mRNA Vaccines & Therapeutics Market Size by Country
  • 6.3.1 North America mRNA Vaccines & Therapeutics Sales by Country (2016-2027)
  • 6.3.2 North America mRNA Vaccines & Therapeutics Revenue by Country (2016-2027)
  • 6.3.3 U.S.
  • 6.3.4 Canada

7 Europe

• 7.1 Europe mRNA Vaccines & Therapeutics Market Size by Type
  • 7.1.1 Europe mRNA Vaccines & Therapeutics Sales by Type (2017-2027)
  • 7.1.2 Europe mRNA Vaccines & Therapeutics Revenue by Type (2017-2027)
• 7.2 Europe mRNA Vaccines & Therapeutics Market Size by Application
  • 7.2.1 Europe mRNA Vaccines & Therapeutics Sales by Application (2017-2027)
  • 7.2.2 Europe mRNA Vaccines & Therapeutics Revenue by Application (2017-2027)
• 7.3 Europe mRNA Vaccines & Therapeutics Market Size by Country
  • 7.3.1 Europe mRNA Vaccines & Therapeutics Sales by Country (2017-2027)
  • 7.3.2 Europe mRNA Vaccines & Therapeutics Revenue by Country (2017-2027)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific mRNA Vaccines & Therapeutics Market Size by Type
  • 8.1.1 Asia Pacific mRNA Vaccines & Therapeutics Sales by Type (2018-2027)
  • 8.1.2 Asia Pacific mRNA Vaccines & Therapeutics Revenue by Type (2018-2027)
• 8.2 Asia Pacific mRNA Vaccines & Therapeutics Market Size by Application
  • 8.2.1 Asia Pacific mRNA Vaccines & Therapeutics Sales by Application (2018-2027)
  • 8.2.2 Asia Pacific mRNA Vaccines & Therapeutics Revenue by Application (2018-2027)
• 8.3 Asia Pacific mRNA Vaccines & Therapeutics Market Size by Region
  • 8.3.1 Asia Pacific mRNA Vaccines & Therapeutics Sales by Region (2018-2027)
  • 8.3.2 Asia Pacific mRNA Vaccines & Therapeutics Revenue by Region (2018-2027)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia

9 Latin America

• 9.1 Latin America mRNA Vaccines & Therapeutics Market Size by Type
  • 9.1.1 Latin America mRNA Vaccines & Therapeutics Sales by Type (2019-2027)
  • 9.1.2 Latin America mRNA Vaccines & Therapeutics Revenue by Type (2019-2027)
• 9.2 Latin America mRNA Vaccines & Therapeutics Market Size by Application
  • 9.2.1 Latin America mRNA Vaccines & Therapeutics Sales by Application (2019-2027)
  • 9.2.2 Latin America mRNA Vaccines & Therapeutics Revenue by Application (2019-2027)
• 9.3 Latin America mRNA Vaccines & Therapeutics Market Size by Country
  • 9.3.1 Latin America mRNA Vaccines & Therapeutics Sales by Country (2019-2027)
  • 9.3.2 Latin America mRNA Vaccines & Therapeutics Revenue by Country (2019-2027)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

6 Middle East and Africa

• 6.1 Middle East and Africa mRNA Vaccines & Therapeutics Market Size by Type
  • 6.1.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales by Type (2016-2027)
  • 6.1.2 Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Type (2016-2027)
• 6.2 Middle East and Africa mRNA Vaccines & Therapeutics Market Size by Application
  • 6.2.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales by Application (2016-2027)
  • 6.2.2 Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Application (2016-2027)
• 6.3 Middle East and Africa mRNA Vaccines & Therapeutics Market Size by Country
  • 6.3.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales by Country (2016-2027)
  • 6.3.2 Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Country (2016-2027)
  • 6.3.3 Turkey
  • 6.3.4 Saudi Arabia
  • 6.3.5 UAE

11 Company Profiles

• 11.1 Moderna Therapeutics
  • 11.1.1 Moderna Therapeutics Corporation Information
  • 11.1.2 Moderna Therapeutics Overview
  • 11.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 Moderna Therapeutics mRNA Vaccines & Therapeutics Product Description
  • 11.1.5 Moderna Therapeutics Related Developments
• 11.2 CureVac
  • 11.2.1 CureVac Corporation Information
  • 11.2.2 CureVac Overview
  • 11.2.3 CureVac mRNA Vaccines & Therapeutics Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.2.4 CureVac mRNA Vaccines & Therapeutics Product Description
  • 11.2.5 CureVac Related Developments
• 11.3 Translate Bio
  • 11.3.1 Translate Bio Corporation Information
  • 11.3.2 Translate Bio Overview
  • 11.3.3 Translate Bio mRNA Vaccines & Therapeutics Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.3.4 Translate Bio mRNA Vaccines & Therapeutics Product Description
  • 11.3.5 Translate Bio Related Developments
• 11.4 BioNTech
  • 11.4.1 BioNTech Corporation Information
  • 11.4.2 BioNTech Overview
  • 11.4.3 BioNTech mRNA Vaccines & Therapeutics Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.4.4 BioNTech mRNA Vaccines & Therapeutics Product Description
  • 11.4.5 BioNTech Related Developments
• 11.5 Sangamo Therapeutics
  • 11.5.1 Sangamo Therapeutics Corporation Information
  • 11.5.2 Sangamo Therapeutics Overview
  • 11.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.5.4 Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Description
  • 11.5.5 Sangamo Therapeutics Related Developments
• 11.6 Argos Therapeutics
  • 11.6.1 Argos Therapeutics Corporation Information
  • 11.6.2 Argos Therapeutics Overview
  • 11.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.6.4 Argos Therapeutics mRNA Vaccines & Therapeutics Product Description
  • 11.6.5 Argos Therapeutics Related Developments
• 11.7 In-Cell-Art
  • 11.7.1 In-Cell-Art Corporation Information
  • 11.7.2 In-Cell-Art Overview
  • 11.7.3 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.7.4 In-Cell-Art mRNA Vaccines & Therapeutics Product Description
  • 11.7.5 In-Cell-Art Related Developments
• 11.8 eTheRNA
  • 11.8.1 eTheRNA Corporation Information
  • 11.8.2 eTheRNA Overview
  • 11.8.3 eTheRNA mRNA Vaccines & Therapeutics Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.8.4 eTheRNA mRNA Vaccines & Therapeutics Product Description
  • 11.8.5 eTheRNA Related Developments
• 11.9 Ethris
  • 11.9.1 Ethris Corporation Information
  • 11.9.2 Ethris Overview
  • 11.9.3 Ethris mRNA Vaccines & Therapeutics Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.9.4 Ethris mRNA Vaccines & Therapeutics Product Description
  • 11.9.5 Ethris Related Developments
• 11.10 Tiba Biotechnology
  • 11.10.1 Tiba Biotechnology Corporation Information
  • 11.10.2 Tiba Biotechnology Overview
  • 11.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.10.4 Tiba Biotechnology mRNA Vaccines & Therapeutics Product Description
  • 11.10.5 Tiba Biotechnology Related Developments
• 11.1 Moderna Therapeutics
  • 11.1.1 Moderna Therapeutics Corporation Information
  • 11.1.2 Moderna Therapeutics Overview
  • 11.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 Moderna Therapeutics mRNA Vaccines & Therapeutics Product Description
  • 11.1.5 Moderna Therapeutics Related Developments

12 Value Chain and Sales Channels Analysis

• 12.1 mRNA Vaccines & Therapeutics Value Chain Analysis
• 12.2 mRNA Vaccines & Therapeutics Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 mRNA Vaccines & Therapeutics Production Mode & Process
• 12.4 mRNA Vaccines & Therapeutics Sales and Marketing
  • 12.4.1 mRNA Vaccines & Therapeutics Sales Channels
  • 12.4.2 mRNA Vaccines & Therapeutics Distributors
• 12.5 mRNA Vaccines & Therapeutics Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 mRNA Vaccines & Therapeutics Industry Trends
• 13.2 mRNA Vaccines & Therapeutics Market Drivers
• 13.3 mRNA Vaccines & Therapeutics Market Challenges
• 13.4 mRNA Vaccines & Therapeutics Market Restraints

14 Key Findings in The Global mRNA Vaccines & Therapeutics Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details

mRNA Vaccines & Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global mRNA Vaccines & Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Infectious Disease Vaccines
Cancer Vaccines

Segment by Application
Standardized Preselected
Prophylactic Vaccines
Individualized Shared Antigens
Synthetic Self-Amplifying Mrna Vaccines for Pandemic Outbreaks
Therapeutic Vaccines
Individualized Neoantigens

By Company
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia